Biotech RadarJobs updated

COMPANY

Neobiosis

neobiosis.com ↗

Clinical Phase 1

Profile checked Oct 10, 2026

Keywords: Post-Acute COVID-19 Syndrome Cognitive Impairment Neurological Complication VIX001

1Trials (company is sponsor)

Timeline

  1. Trial start Phase 1: Safety, Efficacy, and Dosing of VIX001 in Patients With Neurological Symptoms of Post Acute COVID-19 Syndrome (PACS). source ↗

Clinical trials (lead sponsor) 1

RecordTitlePhaseStatusStartPrimary completion
NCT05947617Safety, Efficacy, and Dosing of VIX001 in Patients With Neurological Symptoms of Post Acute COVID-19 Syndrome (PACS).Phase 1Unknown status (ClinicalTrials.gov)Oct 1, 2023Apr 1, 2025 (estimated)
Feedback